Literature DB >> 6124133

Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication.

M I Herz, H V Szymanski, J C Simon.   

Abstract

Because of neuroleptics' potential long-term side effects, the authors conducted a pilot study of an alternative to maintenance medication for stable schizophrenic outpatients. The doses of 19 patients were gradually reduced to zero over 8 weeks, and medication was then given only when a patient experienced early signs of relapse. The patients attended weekly group therapy and were closely monitored for prodromal signs, especially at times of stress; significant others helped observe patients. Five patients experienced increased symptoms during the drug washout period and were dropped from the study; of the remaining 14, 10 remained stable on the intermittent medication protocol.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124133     DOI: 10.1176/ajp.139.7.918

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

1.  Soteria Berne: an innovative milieu therapeutic approach to acute schizophrenia based on the concept of affect-logic.

Authors:  Luc Ciompi; Holger Hoffmann
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

2.  Diagnostic validity of basic symptoms.

Authors:  J Klosterkötter; H Ebel; F Schultze-Lutter; E M Steinmeyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 3.  Pharmacological treatment of patients with schizophrenia. Past and present problems and potential future therapy.

Authors:  D A Johnson
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 4.  Antipsychotic medication for early episode schizophrenia.

Authors:  John Bola; Dennis Kao; Haluk Soydan
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 5.  The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.

Authors:  Marc De Hert; Jan Sermon; Paul Geerts; Kristof Vansteelandt; Joseph Peuskens; Johan Detraux
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

6.  William T. Carpenter Jr: 35 years of clinical trials.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

Review 7.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 8.  Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies.

Authors:  N R Schooler; S J Keith; J B Severe; S M Matthews
Journal:  Psychiatr Q       Date:  1995

9.  Neuroleptic medication and prescription practices with sheltered-care residents: a 12-year perspective.

Authors:  S P Segal; D Cohen; S R Marder
Journal:  Am J Public Health       Date:  1992-06       Impact factor: 9.308

10.  Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years.

Authors:  A G Jolley; S R Hirsch; E Morrison; A McRink; L Wilson
Journal:  BMJ       Date:  1990-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.